Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

被引：0
|
作者：
D A Reardon
A Desjardins
J J Vredenburgh
S Gururangan
J H Sampson
S Sathornsumetee
R E McLendon
J E Herndon
J E Marcello
J Norfleet
A H Friedman
D D Bigner
H S Friedman
机构：
[1] The Preston Robert Tisch Brain Tumor Center,Department of Surgery
[2] Duke University Medical Center,Department of Pediatrics
[3] The Preston Robert Tisch Brain Tumor Center,Department of Medicine
[4] Duke University Medical Center,Department of Pathology
[5] The Preston Robert Tisch Brain Tumor Center,undefined
[6] Duke University Medical Center,undefined
[7] The Preston Robert Tisch Brain Tumor Center,undefined
[8] Duke University Medical Center,undefined
[9] Cancer Center Biostatistics,undefined
[10] The Preston Robert Tisch Brain Tumor Center,undefined
[11] Duke University Medical Center,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
malignant glioma; glioblastoma; angiogenesis; bevacizumab; vascular endothelial growth factor; metronomic chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1986 / 1994
页数：8
相关论文
共 50 条
  • [31] Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma†
    Nagane, Motoo
    Nishikawa, Ryo
    Narita, Yoshitaka
    Kobayashi, Hiroyuki
    Takano, Shingo
    Shinoura, Nobusada
    Aoki, Tomokazu
    Sugiyama, Kazuhiko
    Kuratsu, Junichi
    Muragaki, Yoshihiro
    Sawamura, Yutaka
    Matsutani, Masao
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (10) : 887 - 895
  • [32] RETROSPECTIVE STUDY OF BEVACIZUMAB AND ETOPOSIDE COMBINATION CHEMOTHERAPY IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS WHO FAILED BEVACIZUMAB
    Fu, Beverly Dan
    Linskey, Mark
    Bota, Daniela
    NEURO-ONCOLOGY, 2010, 12 : 44 - 44
  • [33] Second Line Chemotherapy with Docetaxel in Patients with Recurrent Malignant Glioma: A Phase II Study
    M. Sanson
    M. Napolitano
    R. Yaya
    F. Keime-Guibert
    Ph Broët
    K. Hoang-Xuan
    J.Y. Delattre
    Journal of Neuro-Oncology, 2000, 50 : 245 - 249
  • [34] Second line chemotherapy with docetaxel in patients with recurrent malignant glioma:: a phase II study
    Sanson, M
    Napolitano, M
    Yaya, R
    Keime-Guibert, F
    Broët, P
    Hoang-Xuan, K
    Delattre, JY
    JOURNAL OF NEURO-ONCOLOGY, 2000, 50 (03) : 245 - 249
  • [35] BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL
    Sithornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Janney, D. E.
    Friedman, Allan H.
    Friedman, Henry S.
    Reardon, David A.
    NEURO-ONCOLOGY, 2009, 11 (06) : 926 - 926
  • [36] Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors
    Needle, MN
    Molloy, PT
    Geyer, JR
    HermanLiu, A
    Belasco, JB
    Goldwein, JW
    Sutton, L
    Phillips, PC
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 29 (01): : 28 - 32
  • [37] PHASE II STUDY OF BEVACIZUMAB PLUS IRINOTECAN IN CHILDREN WITH RECURRENT MALIGNANT GLIOMA AND DIFFUSE BRAINSTEM GLIOMA-A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-022)
    Gururangan, Sridharan
    Chi, Susan
    Onar, Arzu
    Packer, Roger
    Poussainr, Tina Young
    Gilbertson, Richard
    Friedman, Henry
    Kun, Larry
    Boyett, James
    NEURO-ONCOLOGY, 2008, 10 (05) : 833 - 833
  • [38] VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL
    Peters, Katherine B.
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Coan, April
    McSherry, Frances
    Lipp, Eric
    Brickhouse, Alise
    Massey, Woody
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2012, 14 : 81 - 81
  • [39] Metronomic chemotherapy with and without bevacizumab for advanced breast cancer: a randomized phase II study
    Burstein, HJ
    Spigel, D
    Kindsvogel, K
    Parker, LM
    Bunnell, CA
    Partridge, AH
    Come, SE
    Ryan, PD
    Gelman, R
    Winer, EP
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S6 - S6
  • [40] Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma
    Reardon, DA
    Quinn, JA
    Vredenburgh, J
    Rich, JN
    Gururangan, S
    Badruddoja, M
    Herndon, JE
    Dowell, JM
    Friedman, AH
    Friedman, HS
    CANCER, 2005, 103 (02) : 329 - 338
12345